Meds & supplements › Zolmitriptan
Medicine · Serotonin-1b and Serotonin-1d Receptor Agonist
Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks.
Zolmitriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache.
Generic Name: zolmitriptan (zol-mi-trip-tan)
Please read this leaflet carefully before you take ZOMIG Tablets. This provides a summary of the information available on your medicine. Please do not throw away this leaflet until you have finished your medicine. You may need to read this leaflet again. This leaflet does not contain all the information on ZOMIG Tablets. For further information or advice, ask your doctor or pharmacist.
The name of your medicine is ZOMIG Tablets. It can be obtained only by prescription from your doctor. The decision to use ZOMIG Tablets is one that you and your doctor should make jointly, taking into account your individual preferences and medical circumstances. If you have risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or you are postmenopausal or a male over the age of 40), you should tell your doctor, who should evaluate you for heart disease in order to determine if ZOMIG Tablets are appropriate for you. This medicine was prescribed for you to treat your particular condition and should not be used by others or for any other condition.
ZOMIG and ZOMIG-ZMT are registered trademarks of the AstraZeneca group of companies.
Other brands mentioned are trademarks of their respective owners and are not trademarks of the AstraZeneca group of companies. The makers of these brands are not affiliated with AstraZeneca or its products.
© AstraZeneca 2007, 2008
ZOMIG ® (zolmitriptan) Tablets
Manufactured for:
AstraZeneca Pharmaceuticals LP
Wilmington, Delaware 19850
By: IPR Pharmaceuticals, Inc.
Canóvanas, PR 00729
ZOMIG-ZMT ® (zolmitriptan) Orally Disintegrating Tablets
Manufactured for:
AstraZeneca Pharmaceuticals LP
Wilmington, Delaware 19850
By: CIMA Labs, Inc.
Eden Prairie, Minnesota 55344
Rev 10/08 SIC 30086–05
sofidex [Internet]. Daloreum; c2026. Zolmitriptan; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/zolmitriptan
sofidex. (2026, August 3). Zolmitriptan. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/zolmitriptan
Zolmitriptan. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/zolmitriptan
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.